This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Achillion Pharmaceuticals, Inc.

Drug Names(s): ACH-2684.Na, ACH-0142684.Na, Neceprevir sodium

Description: ACH-2684 is a highly potent, pan-genotypic inhibitor of HCV NS3 protease with pico-molar potency. Achillion has demonstrated in vitro that ACH-2684 can be used in combination with other HCV inhibitors, and that it is synergistic with NS5B nucleoside polymerase inhibitors.

ACH-2684 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug